Bulletin Of Experimental Biology And Medicine

Journal Title：Bulletin Of Experimental Biology And Medicine

Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, etc. Novel trends in science are covered in new sections of the journal - Biogerontology and Human Ecology - that first appeared in 2005.

World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal Cell Technologies in Biology and Medicine (a new Russian Academy of Medical Sciences publication since 2005). It publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors, pilot projects on clinical use of stem and progenitor cells.

The Russian Volume Year is published in English from April.

《實驗生物學和醫學公報》刊登了原始的同行評議研究論文和關于生理學、生物化學、生物物理學、藥理學、免疫學、微生物學、遺傳學、腫瘤學等領域優先新研究成果的簡要報告。該期刊的新欄目——生物老年學和人類生態學——涵蓋了科學領域的新趨勢，該欄目于 2005 年首次出現。

世界科學界對干細胞的興趣促使《實驗生物學和醫學公報》被收錄為季刊科學雜志《生物和醫學細胞技術》（自 2005 年起成為俄羅斯醫學科學院的新刊物）。它只發表來自領先研究機構的原創論文，內容涉及干細胞和祖細胞的分子生物學、干細胞作為基因治療的基礎、細胞間通訊的分子語言、細胞因子、趨化因子、生長和其他因素、干細胞和祖細胞臨床應用的試點項目。

俄羅斯卷年刊從 4 月開始以英文出版。

Bulletin Of Experimental Biology And Medicine創刊于1956年，由Springer US出版商出版，收稿方向涵蓋醫學 - 醫學：研究與實驗全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 約2月 ，影響因子指數0.9，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。